CN Patent

CN101631568B — 低聚物-蛋白酶抑制剂偶联物

Assigned to Nektar Therapeutics · Expires 2012-08-22 · 14y expired

What this patent protects

本发明提供由水溶性低聚物的共价连接来化学修饰的小分子药物。本发明的偶联物当通过许多施用途径中的任何一种来施用时，显示出不同于没有连接到水溶性低聚物的小分子的特征。

USPTO Abstract

本发明提供由水溶性低聚物的共价连接来化学修饰的小分子药物。本发明的偶联物当通过许多施用途径中的任何一种来施用时，显示出不同于没有连接到水溶性低聚物的小分子的特征。

Drugs covered by this patent

naloxegol-oxalate (NALOXEGOL OXALATE)

Patent Metadata

Patent number: CN101631568B
Jurisdiction: CN
Classification: —
Expires: 2012-08-22
Drug substance claim: No
Drug product claim: No
Assignee: Nektar Therapeutics
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.